Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  TEL AVIV STOCK EXCHANGE  >  Teva Pharmaceutical Industries Limited    TEVA   IL0006290147

Delayed Quote. Delayed  - 09/01 03:47:31 am
25100 ILa   -2.33%
08/28DJMylan's Holders Approve Perrigo Purchase
08/25DJLILLY : U.S. Court Rules in its Favor on Alimta Patent
08/20 TEVA PHARMACEUT : ex-dividend day for interim dividend
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 
Latest news on TEVA PHARMACEUTICAL INDUST
08/28DJMylan's Holders Approve Perrigo Purchase
08/27 TEVA PHARMACEUTICAL : Patent Issued for Risperidone Microparticles Formed by Sub..
08/27 TEVA PHARMACEUTICAL : Trademark Application for "MEDISEEN" Filed by Teva Pharmac..
08/27 TEVA PHARMACEUTICALS : USA's Trademark Application for "WILPAXA" Filed
08/27 TEVA PHARMACEUTICAL : An Application for the Trademark "MEDISEEN EHEALTH" Has Be..
08/27 TEVA PHARMACEUTICALS : USA's Trademark Application for "KEEVENLY" Filed
08/25DJLILLY : U.S. Court Rules in its Favor on Alimta Patent
08/20 TEVA PHARMACEUTICAL : Announces FDA Acceptance of NDA for SD-809 for Treatment i..
08/20 TEVA PHARMACEUTICAL : Patent Issued for Deuterated N-Ethyl-N-Phenyl-1,2-Dihydro-..
08/20 TEVA PHARMACEUTICAL INDUSTRIES LIMIT : ex-dividend day for interim dividend
08/18 Teva likely to oppose Mylan's bid to take over Perrigo
08/18 TEVA PHARMACEUTICAL : Shareholder Notice: Investigation for Certain Investors Wh..
08/14DJMylan, Perrigo Notch Wins in Their Takeover Fight
08/13 TEVA PHARMACEUTICAL : Huntington new drug application accepted by FDA
08/12 ALLERGAN : is earning bridge for Teva (Goldman Sachs)
08/12 TEVA PHARMACEUTICAL : FDA accepts Teva's Huntington new drug application
08/12 TEVA PHARMACEUTICAL : and Immuneering Announce 's Purchase of 51% Equity Share o..
08/12 TEVA PHARMACEUTICAL : An Application for the Trademark "ENJUVIA" Has Been Filed ..
08/12 TEVA PHARMACEUTICAL : Announces FDA Acceptance of NDA for SD-809 for Treatment i..
08/10 TEVA PHARMACEUTICAL : Xenon Pharmaceuticals Reports Second Quarter 2015 Financia..
08/06 Mylan CEO says still wants Perrigo but has other options
08/06DJPatrick Drahi Cements Control of Altice in Move to Netherlands
08/06DJPATRICK DRAHI : Patrick Drahi to Move Altice to the Netherlands
08/06DJMylan Raises Outlook After Stronger Generics Sales
08/06DJAllergan Swings to Loss on Deals-Related Charges -- Update
08/06DJAllergan Swings to Loss on Deals-Related Charges
08/06DJAllergan Swings to Loss on Deals-Related Charges
08/05 TEVA PHARMACEUTICAL : Trademark Application for "VELIVET" Filed by Teva Pharmace..
08/05 TEVA PHARMACEUTICAL : Patent Issued for Nilotinib Salts and Crystalline Forms
08/05 Perrigo CEO says no easy path for Mylan to acquire company
08/05 TEVA PHARMACEUTICAL : Announces European Medicines Agency EMA Confirms Successfu..
08/05DJAllergan Changes Deal for Kythera
08/05DJAllergan Changes Its $2.1 Billion Deal for Kythera to All Cash
08/05 Teva Gets $33.75 Billion Financing Commitment
08/05 Teva Gets $33.75 Billion Financing Commitment
08/04DJShire Mounts $30.6 Billion Bid for Biotech
08/04 SAGENT PHARMACEUTICALS : Board Appoints Allan Oberman as Chief Executive Officer
08/03 PFIZER : teams with Synthon on generic Copaxone
08/03 TEVA PHARMACEUTICAL : and Immuneering Announce ’s Purchase of 51% Equity S..
08/03 TEVA PHARMACEUTICAL : Sagent Pharmaceuticals : Board Appoints Allan Oberman as C..
08/02 TEVA PHARMACEUTICAL : shareholders asked to approve CEO pay hike
08/01 ALLERGAN : BRIEF: Teva secures $34b financing for Allergan acquisition
07/31 TEVA PHARMACEUTICAL : Secures $33.75 Billion Financing Commitment
07/31 Healthcare deals lift July to seventh busiest M&A month on record
07/31 TEVA PHARMACEUTICAL : Reports European Medicines Agency Confirms Validation of R..
07/30DJAmgen Raises 2015 Outlook, Results Beat Expectations
07/30DJTeva Profit Falls on Legal Expenses
07/30DJTeva Profit Falls as Legal and Restructuring Expenses Rise
07/30 Teva's MS drug Copaxone has strong second-quarter sales
07/30 TEVA PHARMACEUTICAL : Reports Strong Second Quarter 2015 Results and Raises Guid..
07/29 TEVA PHARMACEUTICAL : to Report Second Quarter 2015 Financial Results on July 30..
07/29 TEVA PHARMACEUTICAL : protects itself against hostile takeover
07/29DJMylan Gets European Regulator's Approval for Perrigo Deal
07/29DJMylan Gets European Regulator's Approval for Perrigo Deal
07/29 ALLERGAN : Teva to acquire allergan generics for $40.5 billion
07/29 TEVA PHARMACEUTICAL : Introduces Educational Initiative to Provide Women with Fa..
07/28 TEVA PHARMACEUTICAL : Announces European Medicines Agency (EMA) Confirms Success..
07/28 Hikma to buy Boehringer's U.S. generic drug business for $2.65 billion
07/28 TEVA PHARMACEUTICAL : to buy Allergan generic business for $40.5 billion, drops ..
07/28 Hikma to buy Boehringer's U.S. generics unit for $2.65 billion
07/28 TEVA PHARMACEUTICAL : to purchase Allergan's generic drugs unit for $40.5 billio..
07/27 Mylan independence from Teva's embrace comes with a price
07/27 ALLERGAN : Business Highlights
07/27DJMylan's Leverage to Resist Teva Deal Reveals Shift in Rules
07/27 Allergan CEO, fresh off one deal, sets sights on others
07/27DJMARKET SNAPSHOT : U.S. Stocks Follow China's Rout With 5th Straight Decline
07/27DJMARKET SNAPSHOT : U.S. Stocks Follow China's Rout With
07/27 RESTAURANT BRANDS : Teva and Restaurant Brands are big market movers
07/27 ALLERGAN : Teva buying Allergan Generics for $40.5b
07/27 ALLERGAN : BRIEF: Trading in Teva suspended
07/27 Teva drops bid for Mylan, buys Allergan's generics unit for $40.5 billion
07/27 TEVA PHARMACEUTICAL : Strong shekel hits Teva's second quarter revenue
07/27 ALLERGAN : acquisition a game changer (Teva CEO)
07/27 Analysts expect more tie-ups in generic drug business
07/27DJMylan's Leverage to Resist Teva Deal Reveals Shift in Rules
1  2  3  4  5  6  7  8  9  10Next
Advertisement
Chart
Duration : Period :
Teva Pharmaceutical Indust Technical Analysis Chart | TEVA | IL0006290147 | 4-Traders
Income Statement Evolution
More Financials